IMVT
Immunovant, Inc. · Healthcare
Director Andrew J. Fromkin sold $7.4M of Immunovant, Inc.
Sold$7,438,111
$33.51Price
221,951Shares
−75%Stake
What IMVT did after the filing
- The stock from Mon, Jun 1 open, $33.00
- +20.8%
- S&P 500, same days
- −0.1%
Measured over 30 trading days, to the Jul 15 close.
Traded Thu, May 28. Filed Fri, May 29, 4:04 PM ET, after the close. Returns use the Jun 1 open and the Jul 15 close. Not investment advice.